Emerson Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$354K Hold
12,583
0.07% 112
2015
Q4
$385K Sell
12,583
-1,127
-8% -$35.5K 0.08% 105
2015
Q3
$409K Buy
13,710
+312
+2% +$10K 0.08% 100
2015
Q2
$426K Sell
13,398
-3,385
-20% -$110K 0.08% 110
2015
Q1
$554K Buy
16,783
+1,492
+10% +$47.4K 0.1% 101
2014
Q4
$452K Buy
15,291
+637
+4% +$18.3K 0.09% 114
2014
Q3
$411K Buy
14,654
+12
+0.1% +$337 0.08% 120
2014
Q2
$412K Buy
14,642
+342
+2% +$9.75K 0.08% 121
2014
Q1
$436K Buy
14,300
+1,478
+12% +$44.1K 0.09% 110
2013
Q4
$373K Buy
12,822
+831
+7% +$24.2K 0.08% 115
2013
Q3
$327K Buy
11,991
+2,838
+31% +$77.2K 0.07% 117
2013
Q2
$243K Buy
+9,153
New +$253K 0.06% 125

Other funds holding PFE

Emerson Investment Management's PFE Position: Q1 2016 in Review

Emerson Investment Management held its Pfizer (PFE) position steady in Q1 2016 at 12,583 shares worth $354K. The position accounts for 0.07% of the portfolio, ranked #112.

Emerson Investment Management first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $554K in Q1 2015. 1,968 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • Emerson Investment Management held 12,583 shares of Pfizer worth $354K as of Q1 2016.
  • Emerson Investment Management left its Pfizer share count unchanged in Q1 2016.
  • Pfizer made up 0.07% of Emerson Investment Management's portfolio in Q1 2016, its #112 holding.
  • Emerson Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
  • Emerson Investment Management's Pfizer position peaked at $554K in Q1 2015.
  • 1,968 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Emerson Investment Management's 13F filing for Q1 2016, filed 9 May 2016.